Your browser is no longer supported. Please, upgrade your browser.
Settings
ABIO ARCA biopharma, Inc. daily Stock Chart
ABIO [NASD]
ARCA biopharma, Inc.
Index- P/E- EPS (ttm)-1.89 Insider Own1.20% Shs Outstand9.22M Perf Week-2.04%
Market Cap22.13M Forward P/E- EPS next Y- Insider Trans39.81% Shs Float9.10M Perf Month-2.04%
Income-17.10M PEG- EPS next Q- Inst Own59.30% Short Float0.99% Perf Quarter-7.69%
Sales- P/S- EPS this Y0.30% Inst Trans-13.17% Short Ratio2.60 Perf Half Y-17.24%
Book/sh1.98 P/B1.21 EPS next Y- ROA-64.30% Target Price16.50 Perf Year-16.67%
Cash/sh2.08 P/C1.15 EPS next 5Y- ROE-70.20% 52W Range2.15 - 3.36 Perf YTD-15.79%
Dividend- P/FCF- EPS past 5Y39.50% ROI- 52W High-28.57% Beta1.91
Dividend %- Quick Ratio7.90 Sales past 5Y- Gross Margin- 52W Low11.63% ATR0.12
Employees20 Current Ratio7.90 Sales Q/Q- Oper. Margin- RSI (14)50.69 Volatility5.24% 5.05%
OptionableNo Debt/Eq0.00 EPS Q/Q-18.40% Profit Margin- Rel Volume0.91 Prev Close2.40
ShortableYes LT Debt/Eq0.00 EarningsJun 20 AMC Payout- Avg Volume34.68K Price2.40
Recom2.00 SMA201.96% SMA50-0.88% SMA200-4.66% Volume11,535 Change0.00%
Oct-09-13Initiated Dawson James Buy $3.75
Jun-20-17 08:30AM  ARCA Biopharma Announces Database Lock for GENETIC-AF Phase 2B Interim Efficacy Analysis DSMB Recommendation Anticipated in August 2017 GlobeNewswire
May-15-17 08:30AM  ARCA Biopharma Announces First Quarter 2017 Financial Results and Provides Business Update GlobeNewswire
Apr-26-17 08:30AM  ARCA biopharma Announces 200th Patient Randomized into the GENETIC-AF Seamless Design Phase 2B/3 Clinical Trial Business Wire
Apr-18-17 08:30AM  ARCA biopharma to Present at the Planet MicroCap Showcase 2017 Investor Conference Business Wire
Mar-25-17 01:04PM  ARCA BIOPHARMA, INC. Financials
Mar-21-17 04:46PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:30PM  ARCA biopharma Announces Fiscal Year 2016 Financial Results and Provides Business Update Business Wire
04:10PM  ARCA BIOPHARMA, INC. Files SEC form 10-K, Annual Report
Mar-06-17 04:32PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  ARCA biopharma Announces 175th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial Business Wire
Mar-01-17 04:47PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-21-17 08:46AM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
08:30AM  Anders Hove, MD Joins ARCA biopharma Board of Directors Business Wire
Jan-18-17 04:32PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  ARCA biopharma Announces 150th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial Business Wire
Jan-11-17 04:54PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit
Jan-04-17 08:30AM  ARCA biopharma to Present at Biotech Showcase 2017 Business Wire
Dec-20-16 02:26PM  Hedge Funds Arent Crazy About A. M. Castle & Co (CASL) Anymore at Insider Monkey +10.64%
Nov-15-16 08:30AM  StockNewsNow.com Publishes New SNNLive Video Interview with ARCA biopharma, Inc. Provides Company Overview and Discusses Clinical Development PR Newswire -7.07%
Nov-14-16 05:19PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi +5.32%
05:08PM  ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report
04:15PM  ARCA biopharma Announces Third Quarter 2016 Financial Results and Provides Business Update Business Wire
Oct-06-16 04:07PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  ARCA biopharma Announces Randomization of First European Patients in GENETIC-AF Phase 2B/3 Clinical Trial Business Wire
Oct-04-16 08:30AM  ARCA biopharma to Present at the Dawson James Securities Second Annual Growth Stock Conference Business Wire
Sep-13-16 09:00AM  ARCA biopharma Named Winner of Corporate LiveWire Healthcare and Lifesciences Innovation Award Business Wire
Aug-18-16 04:16PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  ARCA biopharma Announces 100th Patient Randomized into the GENETIC-AF Phase 2B/3 Clinical Trial Business Wire
Aug-09-16 04:37PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:30PM  ARCA biopharma Announces Second Quarter 2016 Financial Results and Provides Business Update Business Wire
Aug-03-16 01:37AM  Albioma :ABIO-FR: Earnings Analysis: For the six months ended June 30, 2016 : August 3, 2016
Jun-13-16 05:01PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o
May-11-16 04:57PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi -5.56%
04:49PM  ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report
04:30PM  ARCA biopharma Announces First Quarter 2016 Financial Results and Provides Business Update Business Wire
Apr-18-16 04:31PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  ARCA biopharma Announces 75th Patient Enrolled in GENETIC-AF Phase 2B/3 Clinical Trial Business Wire
Mar-17-16 04:44PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:30PM  ARCA biopharma Announces Fiscal Year 2015 Financial Results and Provides Business Update Business Wire
04:14PM  ARCA BIOPHARMA, INC. Files SEC form 10-K, Annual Report
02:25PM  Bearish case for Valeant
Mar-07-16 04:32PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibit
Feb-16-16 04:41PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-12-16 08:46AM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits -13.10%
08:30AM  GENETIC-AF Clinical Trial for Prevention of Atrial Fibrillation Enrolls 50th Patient Business Wire
Dec-08-15 09:00AM  Applying Lessons from KBIO Accesswire
Nov-30-15 09:38AM  2 Micro-Cap Opportunities in Atrial Fibrillation Accesswire
Nov-23-15 03:07PM  Biotechs Under 20 Dollars Poised to Breakout Accesswire +8.75%
Nov-19-15 08:30AM  ARCA biopharma to Present at the 27th Annual Piper Jaffray Healthcare Conference Business Wire
Nov-18-15 09:42AM  2 Important Takeaways from ARCA Biopharma's Q3 Results Accesswire
Nov-12-15 04:43PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:30PM  ARCA biopharma Announces Third Quarter 2015 Financial Results and Provides Business Update Business Wire
Nov-05-15 08:30AM  ARCA biopharma CEO Michael Bristow to Present in Two Sessions at the American Heart Association Scientific Sessions 2015 Business Wire
Nov-04-15 07:47AM  4 Stocks Under $10 Making Big Up Moves on Big Volume at TheStreet
Oct-20-15 02:08PM  Venrocks Latest Pick Shows There Are More Biotech Opportunities to Explore at Insider Monkey
Oct-19-15 09:28AM  Biotech Pullback: Look to Targeted Therapy Companies Accesswire
Oct-06-15 03:01PM  Biotechs take a beating
Sep-15-15 11:20AM  ARCA biopharma (ABIO): Leveraging Genetic Targeting to Better Treat Cardiovascular Disease Accesswire
Sep-09-15 04:06PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
09:00AM  Gencaro Potential Efficacy Preventing Atrial Flutter in Heart Failure Paper to Be Presented at 2015 HFSA Annual Scientific Meeting Business Wire
Sep-03-15 04:32PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial S
Aug-26-15 08:30AM  ARCA biopharma to Present at the Rodman & Renshaw 17th Annual Global Investment Conference Business Wire
Aug-13-15 08:10PM  10-Q for ARCA biopharma, Inc. at Company Spotlight
12:05PM  3 Promising Plays in Healthcare's Most Vibrant Space
Aug-11-15 04:18PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:00PM  ARCA biopharma Announces Second Quarter 2015 Operating Results and Provides Update on Recent Accomplishments Business Wire
Jul-16-15 05:01PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa -10.37%
Jun-29-15 10:27AM  Nutritional Supplement Industry Flexes its Muscles as Natural & Pharmaceutical Supplement Products Continue to Hit the Market - Company Prepares for Strong Revenue Growth in 2nd Half of 2015 PR Newswire
09:15AM  RA Capital Is Expecting A Breakthrough Cancer Drug From This Biotech at Insider Monkey
Jun-23-15 04:37PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Jun-17-15 09:00AM  ARCA biopharma Announces Closing of $37 Million Private Placement Business Wire
Jun-11-15 05:11PM  ARCA BIOPHARMA, INC. Files SEC form 8-K/A, Financial Statements and Exhibits
08:56AM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu
08:50AM  ARCA biopharma Announces $37 Million Private Placement
Jun-05-15 05:00PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events
May-14-15 08:11PM  10-Q for ARCA biopharma, Inc. at Company Spotlight
May-12-15 04:44PM  ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report
May-02-15 08:09PM  10-K for ARCA biopharma, Inc. at Company Spotlight
Apr-14-15 04:00PM  ARCA biopharma Gains on Fast Track Status for Gencaro - Analyst Blog
Apr-13-15 04:45PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
02:47PM  ARCA biopharma (ABIO) Stock Surges Today on FDA Fast Track Designation at TheStreet
08:30AM  ARCA biopharma Receives FDA Fast Track Designation for Gencaro Atrial Fibrillation Development in a Genetically Targeted Heart Failure Population Business Wire
Mar-20-15 05:38AM  ARCA biopharma Provides GENETIC-AF Clinical Trial Update at noodls
Mar-19-15 04:58PM  ARCA BIOPHARMA, INC. Files SEC form 10-K, Annual Report
Mar-16-15 05:03PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:30PM  ARCA biopharma Provides GENETIC-AF Clinical Trial Update Business Wire
Mar-05-15 01:42PM  3 Biotech stocks Under $10 to Trade for Breakouts at TheStreet
Feb-23-15 04:51PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standa
Feb-17-15 05:11PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Feb-04-15 04:36PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  ARCA biopharma Announces Patent Issuance for Methods and Compositions of S-isomer Formulation of Gencaro Business Wire
Dec-30-14 04:37PM  ARCA BIOPHARMA, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers, Financial Statements and Exhibi
Dec-11-14 05:11PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  Arca biopharma Announces Activation of First Canadian Genetic-AF Clinical Trial Site Business Wire
Dec-10-14 05:13PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  ARCA biopharma Receives FDA Orphan Drug Designation for rNAPc2 as a Potential Treatment for Ebola Business Wire
Dec-01-14 05:28PM  ARCA BIOPHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
05:00PM  ARCA biopharma Announces Management Transitions Business Wire
Nov-14-14 07:09PM  10-Q for ARCA biopharma, Inc. Company Spotlight
Nov-12-14 05:14PM  ARCA BIOPHARMA, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
ARCA biopharma, Inc., a biopharmaceutical company, focuses on developing genetically-targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacologically beta-blocker and mild vasodilator, which is in clinical trial for the treatment of atrial fibrillation in chronic heart failure patients with reduced left ventricular ejection fraction. The company has a collaboration agreement with Medtronic, Inc. for the support of GENETIC-AF Phase 2B/Phase 3 clinical trials; and Laboratory Corporation of America to provide the companion diagnostic test and services to support GENETIC-AF trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MITCHELL DANIEL JDirectorMay 02Buy2.7111,00029,81011,000May 03 04:08 PM
Keuer Thomas AChief Operating OfficerApr 04Sale2.4139094014,045Apr 05 04:14 PM
Ozeroff Christopher DavidS.V.P., General CounselApr 04Sale2.414181,00717,517Apr 05 04:15 PM
BRISTOW MICHAEL RPres. & Chief Executive OfficApr 04Sale2.417201,73541,155Apr 05 04:14 PM
Selby Brian L.VP, FinanceApr 03Sale2.461,1142,7401,275Apr 05 04:15 PM
CONWAY ROBERT EDirectorMar 24Buy2.5925,00064,75025,000Mar 27 04:06 PM
Ozeroff Christopher DavidS.V.P., General CounselFeb 28Sale2.614651,21417,935Mar 01 05:11 PM
Keuer Thomas AChief Operating OfficerFeb 28Sale2.614651,21414,435Mar 01 05:11 PM
BRISTOW MICHAEL RPres. & Chief Executive OfficFeb 28Sale2.617631,99141,875Mar 01 05:10 PM
Selby Brian L.VP, FinanceFeb 27Sale2.561614122,389Mar 01 05:12 PM
Keuer Thomas AChief Operating OfficerOct 18Sale2.454831,18414,900Oct 18 04:30 PM
Keuer Thomas AChief Operating OfficerSep 20Sale2.897142,06315,383Sep 21 04:08 PM
BRISTOW MICHAEL RPres. & Chief Executive OfficSep 20Sale2.891,9725,69942,638Sep 21 04:09 PM
Ozeroff Christopher DavidS.V.P., General CounselSep 20Sale2.891,1853,42518,400Sep 21 04:07 PM
Selby Brian L.VP, FinanceSep 19Sale2.914761,3852,550Sep 21 04:06 PM